総胆石症治療の世界市場:規模・現状・予測

QYResearchが発行した調査報告書(DATA910T02534)
◆英語タイトル:Global Choledocholithiasis Treatment Market Size, Status and Forecast 2019-2025
◆商品コード:DATA910T02534
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月28日
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥409,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥614,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥819,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、総胆石症治療の世界市場について調査・分析し、総胆石症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(薬物治療、外科治療)、用途別(病院、専門医、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の総胆石症治療市場動向
・主要企業別マーケットシェア
・総胆石症治療の種類別市場規模2014-2019
(薬物治療、外科治療)
・総胆石症治療の用途別市場規模2014-2019
(病院、専門医、その他)
・総胆石症治療の北米市場:主要企業・種類別/用途別市場規模
・総胆石症治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・総胆石症治療の中国市場:主要企業・種類別/用途別市場規模
・総胆石症治療の日本国内市場:主要企業・種類別/用途別市場規模
・総胆石症治療の東南アジア市場:主要企業・種類別/用途別市場規模
・総胆石症治療のインド市場:主要企業・種類別/用途別市場規模
・総胆石症治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(AstraZeneca、Novartis、GSK、Pfizer、Abbott、GE、Celgene、Eli Lilly)
・総胆石症治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Choledocholithiasis is a condition wherein gall stones are found in the common bile duct instead of the gall bladder.In 2018, the global Choledocholithiasis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Choledocholithiasis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Choledocholithiasis Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study
AstraZeneca
Novartis
GSK
Pfizer
Abbott
GE
Celgene
Eli Lilly

Market segment by Type, the product can be split into
Drug Treatment
Surgical Treatment

Market segment by Application, split into
Hospital
Specialist Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Choledocholithiasis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Choledocholithiasis Treatment development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Choledocholithiasis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Choledocholithiasis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Treatment
1.4.3 Surgical Treatment
1.5 Market by Application
1.5.1 Global Choledocholithiasis Treatment Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Specialist Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Choledocholithiasis Treatment Market Size
2.2 Choledocholithiasis Treatment Growth Trends by Regions
2.2.1 Choledocholithiasis Treatment Market Size by Regions (2019-2025)
2.2.2 Choledocholithiasis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Choledocholithiasis Treatment Market Size by by Players
3.1.1 Global Choledocholithiasis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Choledocholithiasis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Choledocholithiasis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Choledocholithiasis Treatment Key Players Head office and Area Served
3.3 Key Players Choledocholithiasis Treatment Product/Solution/Service
3.4 Date of Enter into Choledocholithiasis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Choledocholithiasis Treatment Market Size by Type (2014-2019)
4.2 Global Choledocholithiasis Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Choledocholithiasis Treatment Market Size (2014-2019)
5.2 Choledocholithiasis Treatment Key Players in North America
5.3 North America Choledocholithiasis Treatment Market Size by Type
5.4 North America Choledocholithiasis Treatment Market Size by Application

6 Europe
6.1 Europe Choledocholithiasis Treatment Market Size (2014-2019)
6.2 Choledocholithiasis Treatment Key Players in Europe
6.3 Europe Choledocholithiasis Treatment Market Size by Type
6.4 Europe Choledocholithiasis Treatment Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Choledocholithiasis Treatment Market Size (2014-2019)
7.2 Choledocholithiasis Treatment Key Players in Asia-Pacific
7.3 Asia-Pacific Choledocholithiasis Treatment Market Size by Type
7.4 Asia-Pacific Choledocholithiasis Treatment Market Size by Application

8 International Players Profiles
8.1 AstraZeneca
8.1.1 AstraZeneca Company Details
8.1.2 Company Description and Business Overview
8.1.3 Choledocholithiasis Treatment Introduction
8.1.4 AstraZeneca Revenue in Choledocholithiasis Treatment Business (2014-2019))
8.1.5 AstraZeneca Recent Development
8.2 Novartis
8.2.1 Novartis Company Details
8.2.2 Company Description and Business Overview
8.2.3 Choledocholithiasis Treatment Introduction
8.2.4 Novartis Revenue in Choledocholithiasis Treatment Business (2014-2019)
8.2.5 Novartis Recent Development
8.3 GSK
8.3.1 GSK Company Details
8.3.2 Company Description and Business Overview
8.3.3 Choledocholithiasis Treatment Introduction
8.3.4 GSK Revenue in Choledocholithiasis Treatment Business (2014-2019)
8.3.5 GSK Recent Development
8.4 Pfizer
8.4.1 Pfizer Company Details
8.4.2 Company Description and Business Overview
8.4.3 Choledocholithiasis Treatment Introduction
8.4.4 Pfizer Revenue in Choledocholithiasis Treatment Business (2014-2019)
8.4.5 Pfizer Recent Development
8.5 Abbott
8.5.1 Abbott Company Details
8.5.2 Company Description and Business Overview
8.5.3 Choledocholithiasis Treatment Introduction
8.5.4 Abbott Revenue in Choledocholithiasis Treatment Business (2014-2019)
8.5.5 Abbott Recent Development
8.6 GE
8.6.1 GE Company Details
8.6.2 Company Description and Business Overview
8.6.3 Choledocholithiasis Treatment Introduction
8.6.4 GE Revenue in Choledocholithiasis Treatment Business (2014-2019)
8.6.5 GE Recent Development
8.7 Celgene
8.7.1 Celgene Company Details
8.7.2 Company Description and Business Overview
8.7.3 Choledocholithiasis Treatment Introduction
8.7.4 Celgene Revenue in Choledocholithiasis Treatment Business (2014-2019)
8.7.5 Celgene Recent Development
8.8 Eli Lilly
8.8.1 Eli Lilly Company Details
8.8.2 Company Description and Business Overview
8.8.3 Choledocholithiasis Treatment Introduction
8.8.4 Eli Lilly Revenue in Choledocholithiasis Treatment Business (2014-2019)
8.8.5 Eli Lilly Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Choledocholithiasis Treatment Key Market Segments
Table Key Players Choledocholithiasis Treatment Covered
Table Global Choledocholithiasis Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Drug Treatment Figures
Table Key Players of Drug Treatment
Figuer Surgical Treatment Figures
Table Key Players of Surgical Treatment
Table Global Choledocholithiasis Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Choledocholithiasis Treatment Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Specialist Clinic Case Studies
Figure Others Case Studies
Figure Choledocholithiasis Treatment Report Years Considered
Figure Global Choledocholithiasis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Choledocholithiasis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Choledocholithiasis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Choledocholithiasis Treatment Market Share by Regions 2014-2019
Figure Global Choledocholithiasis Treatment Market Share by Regions 2014-2019
Figure Global Choledocholithiasis Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Choledocholithiasis Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Choledocholithiasis Treatment Market Share by by Players (2014-2019)
Figure Global Choledocholithiasis Treatment Market Share by by Players in 2018
Table Global Choledocholithiasis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Choledocholithiasis Treatment Product/Solution/Service
Table Date of Enter into Choledocholithiasis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Choledocholithiasis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Choledocholithiasis Treatment Market Size Share by Type (2014-2019)
Figure Global Choledocholithiasis Treatment Market Size Market Share by Type (2014-2019)
Table Global Choledocholithiasis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Choledocholithiasis Treatment Market Size Share by Application (2014-2019)
Figure Global Choledocholithiasis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Choledocholithiasis Treatment Revenue Market Share by Application in 2018
Figure North America Choledocholithiasis Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Choledocholithiasis Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Choledocholithiasis Treatment Market Share (2018-2019)
Table North America Choledocholithiasis Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Choledocholithiasis Treatment Market Share by Type 2014-2019
Table North America Choledocholithiasis Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Choledocholithiasis Treatment Market Share by Application 2014-2019
Figure Europe Choledocholithiasis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Choledocholithiasis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Choledocholithiasis Treatment Market Share (2018-2019)
Table Europe Choledocholithiasis Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Choledocholithiasis Treatment Market Share by Type 2014-2019
Table Europe Choledocholithiasis Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Choledocholithiasis Treatment Market Share by Application 2014-2019
Figure Asia-Pacific Choledocholithiasis Treatment Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Choledocholithiasis Treatment Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Choledocholithiasis Treatment Market Share (2018-2019)
Table Asia-Pacific Choledocholithiasis Treatment Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Choledocholithiasis Treatment Market Share by Type 2014-2019
Table Asia-Pacific Choledocholithiasis Treatment Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Choledocholithiasis Treatment Market Share by Application 2014-2019
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Choledocholithiasis Treatment Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Choledocholithiasis Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Novartis Company Details
Table Novartis Revenue in Choledocholithiasis Treatment Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Choledocholithiasis Treatment Business (2014-2019)
Table Novartis Recent Development
Table GSK Company Details
Table GSK Revenue in Choledocholithiasis Treatment Business 2014-2019 (Million US$)
Figure GSK Revenue Growth Rate in Choledocholithiasis Treatment Business (2014-2019)
Table GSK Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Choledocholithiasis Treatment Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Choledocholithiasis Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Abbott Company Details
Table Abbott Revenue in Choledocholithiasis Treatment Business 2014-2019 (Million US$)
Figure Abbott Revenue Growth Rate in Choledocholithiasis Treatment Business (2014-2019)
Table Abbott Recent Development
Table GE Company Details
Table GE Revenue in Choledocholithiasis Treatment Business 2014-2019 (Million US$)
Figure GE Revenue Growth Rate in Choledocholithiasis Treatment Business (2014-2019)
Table GE Recent Development
Table Celgene Company Details
Table Celgene Revenue in Choledocholithiasis Treatment Business 2014-2019 (Million US$)
Figure Celgene Revenue Growth Rate in Choledocholithiasis Treatment Business (2014-2019)
Table Celgene Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Choledocholithiasis Treatment Business 2014-2019 (Million US$)
Figure Eli Lilly Revenue Growth Rate in Choledocholithiasis Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Global Choledocholithiasis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Choledocholithiasis Treatment Market Size Share by Regions (2019-2025)
Figure Global Choledocholithiasis Treatment Market Size Share by Regions in 2025
Figure North America Choledocholithiasis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Choledocholithiasis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Choledocholithiasis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Choledocholithiasis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Choledocholithiasis Treatment Market Size by Product (2019-2025)
Figure Global Choledocholithiasis Treatment Market Size by Product in 2025
Table Global Choledocholithiasis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Choledocholithiasis Treatment Market Size by Application (2019-2025)
Figure Global Choledocholithiasis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AstraZeneca、Novartis、GSK、Pfizer、Abbott、GE、Celgene、Eli Lilly

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 総胆石症治療の世界市場:規模・現状・予測(Global Choledocholithiasis Treatment Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。